Serum high density lipoprotein (HDL) cholesterol was measured in non-diabetic and diabetic men and women by ultracentrifugation, heparin-manganese chloride precipitation (heparin/Mn++), and sodium phosphotungstate-magnesium chloride precipitation (PT/Mg++). Results of the three methods were closely correlated in both diabetics and non-diabetics. Concentrations were, however, generally lowest by PT/Mg++, intermediate by ultracentrifugation, and highest by heparin/Mn++. These differences were of small magnitude except in the case of diabetic patients treated with insulin. In these patients, serum HDL cholesterol levels were significantly greater than those of non-diabetic patients when measured by heparin/Mn++ and ultracentrifugation, but not by PT/Mg++ This was explained by the finding that the discrepancy between PT/Mg++ and ultracentrifugation increased with increasing HDL cholesterol concentration
References
1.
NikkiläEAHormilaP.Serum lipids and lipoprotein in insulin-treated diabetes. Demonstration of increased high density lipoprotein concentrations. Diabetes1978; 27: 1078–86.
2.
DurringtonPN. Serum high density lipoprotein cholesterol in diabetes mellitus: An analysis of factors which influence its concentration. Clin Chim Acta (in press).
3.
CalvertGDGrahamJJMannikTWisePHYeatesRA. Effects of therapy on plasma-high-density-lipoprotein-cholesterol concentration in diabetes mellitus. Lancet1978; 2: 66–8.
4.
WingerdJPetittiDB. HDL-cholesterol and diabetes. Lancet1978; 2: 676.
5.
KennedyALLappinTRJLaveryTDHaddenDRWeaverJAMontgomeryDAD. Relation of high-density lipoprotein cholesterol concentration to type of diabetes and its control. Br Med J1978; 2: 1191–4.
6.
Lopes-VirellaMFLStonePGColwellJA. Serum high density lipoprotein in diabetic patients. Diabetologia1977; 13: 285–91.
7.
DurringtonPN. HDL cholesterol in diabetes mellitus. Lancet1978; 2: 206.
8.
WilsonDESpigerMJ. A dual precipitation method for quantitative plasma lipoprotein measurement without ultracentrifugation. J Lab Clin Med1973; 82: 473–82.
9.
IshikawaTTBrazierJBSteinerPMStewartLEGartsidePSGlueckCJ. A study of the heparin/manganese chloride method for determination of plasma α-lipoprotein cholesterol concentration. Lipids1976; 11: 628–33.
10.
BachorikPSWoodPDAlbersJJPlasma high-density lipoprotein cholesterol concentrations determined after removal of other lipoproteins by heparin-manganese precipitation or by ultracentrifugation. Clin Chem1976; 22: 1828–34.
11.
Lopes-VirellaMFStonePEllisSColwellJA. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem1977; 23: 882–4.
12.
ThompsonGTraynerI.High-density lipoproteins and peripheral vascular disease. Lancet1979; i: 49.
13.
HavelRJEderHABragdonJH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest1955; 34: 1345–53.
14.
BursteinMSamailleJ.Sur une dosage rapide du cholesterol lié aux α-et aux β-lipoprotéines du serum. Clin Chim Acta1960; 5: 609.
15.
BursteinMScholnickHRMorfinR.Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res1970; 11: 583–95.
16.
SteeleBWKoehlerDFAzarMMBlaszkowskiTPKubaKDempseyME. Enzymatic determinations of cholesterol in high-density-lipoprotein fractions prepared by a precipitation technique. Clin Chem1976; 22: 98–101.
17.
SackettGE. Modification of Bloor's method for the determination of cholesterol in whole blood or blood serum. J Biol Chem1925; 64: 203–5.
18.
StoneMCThorpJM. A new technique for the investigation of the low-density lipoprotein in health and disease. Clin Chim Acta1966; 14: 812–80.
19.
AbrahamECHuffTACopeNDWilsonJBBransomeEDHuismanTHJ. Determination of the glycosylated hemoglobins (HbA1) with a new microcolumn procedure. Suitability of the technique for assessing the clinical management of diabetes mellitus. Diabetes1978; 27: 931–7.
20.
AlbersJJHazzardWR. Immunochemical quantification of human plasma Lp(a) lipoprotein. Lipids1974; 9: 15–26.
21.
SuenramAMcConathyWJAlaupovicP.Evidence for the lipoprotein heterogeneity of human plasma high density lipoproteins isolated by three different procedures. Lipids1979; 14: 505–10.
22.
WeisgraberKHMahleyRW. Apoprotein (E-AII) complex of human plasma lipoproteins. I. A characterization of this mixed disulfide and its identification in a high density lipoprotein subfraction. J Biol Chem1978; 253: 6281–8.
23.
InnerarityTLMahleyRWWeisgraberKHBersotTP. Apoprotein (E-AII) complex of human plasma lipoproteins. II. Receptor binding activity of high density lipoprotein subfraction modulated by the apo (E-AII) complex. J Biol Chem1978; 253: 6287–95.
24.
ShelburneFHQuarfordtSH. The interaction of heparin with an apoprotein of human very low density lipoprotein. J Clin Invest1977; 60: 944–50.
25.
MahleyRWInnerarityTL. Interaction of canine and swine lipoproteins with the low density lipoprotein receptor of fibroblasts as correlated with heparin/manganese precipitability. J Biol Chem1977; 252: 3980–6.
26.
GofmanJWDeLallaOGlazierFThe serum lipoprotein system in health, metabolic disorders, atherosclerosis and coronary artery disease. Plasma1954; 2: 413–84.
27.
AndersonDWNicholsAVPanSSLindgrenFT. High density lipoprotein distribution. Resolution and determination of three major components in a normal population sample. Atherosclerosis1978; 29: 161–79.
28.
RecklessJPDBetteridgeDJWuPPayneBGaltonDJ. High-density and low-density lipoproteins and prevalence of vascular disease in diabetes mellitus. Br Med J1978; 1: 883–6.
29.
GordonTCastelliWPHjortlandMCKannelWBDawberTR. High density lipoprotein as a protective factor against coronary heart disease. The Framingham study. Am J Med1977; 62: 707–14.
30.
MillerNEFørdeOHThelleDSMjøsOD. The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: A prospective case study. Lancet1977; 1: 965–8.
31.
RhoadsGGGulbrandsonCLKaganH.Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men. N Engl J Med1976; 294: 293–8.
